Transparent Process

Structural features within the nascent chain regulate alternative targeting of secretory proteins to mitochondria

Natalie V Pfeiffer, Daniela Dirndorfer, Sven Lang, Ulrike K Resenberger, Lisa M Restelli, Charles Hemion, Margit Miesbauer, Stephan Frank, Albert Neutzner, Richard Zimmermann, Konstanze F Winklhofer, Jörg Tatzelt

Author Affiliations

  1. Natalie V Pfeiffer1,
  2. Daniela Dirndorfer1,
  3. Sven Lang2,,
  4. Ulrike K Resenberger1,,
  5. Lisa M Restelli3,
  6. Charles Hemion4,
  7. Margit Miesbauer1,,
  8. Stephan Frank3,
  9. Albert Neutzner4,
  10. Richard Zimmermann2,
  11. Konstanze F Winklhofer1,5 and
  12. Jörg Tatzelt*,1,5
  1. 1 Neurobiochemistry, Adolf‐Butenandt‐Institute, Ludwig‐Maximilians‐University Munich, Munich, Germany
  2. 2 Medical Biochemistry and Molecular Biology, Saarland University Homburg, Homburg, Germany
  3. 3 Department of Neuropathology, Institute of Pathology, University of Basel, Basel, Switzerland
  4. 4 Department of Biochemistry, and Department for Ophthalmology, University of Basel, Basel, Switzerland
  5. 5 German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
  1. *Corresponding author. Department of Biochemistry, Neurobiochemistry, Ludwig‐Maximilians‐University Munich, Schillerstrasse 44, Munich, 80336, Germany. Tel.:+49 89 2180 75442; Fax:+49 89 2180 75415; E-mail: joerg.tatzelt{at}
  1. These authors contributed equally to this work

  • Present address: Roche Pharma AG, 79639 Grenzach‐Wyhlen, Germany

View Full Text

Subscribers, please sign in with your username and password.

Log in through your institution